Company Quick10K Filing
Texas Republic Capital
10-K 2019-12-31 Filed 2020-03-27
10-Q 2019-09-30 Filed 2019-11-26
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-03-22
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-14
10-K 2017-12-31 Filed 2018-03-13
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-16
10-Q 2016-09-30 Filed 2016-11-10
10-Q 2016-06-30 Filed 2016-08-12
8-K 2020-05-15 Other Events
8-K 2020-05-04 Other Events
8-K 2019-10-11 Officers
8-K 2018-09-12 Officers
8-K 2018-05-08 Shareholder Vote

Texas Republic Capital Financials

TRCC Metrics, Comps, Filings

Quarterly | Annual

Business

Texas Republic Capital Corporation (the “Company”) is the parent holding company of Texas Republic Life Insurance Company (“TRLIC”) and Texas Republic Life Solutions, Inc. (“TRLS”). The Company was incorporated in Texas on May 15, 2012, for the primary purpose of forming and capitalizing a life insurance company subsidiary.

The Texas Department of Insurance approved TRLIC's life insurance charter on August 1, 2016. The Company capitalized TRLIC with $3,000,000 and owns 100% of TRLIC. TRLIC began insurance operations on April 3, 2017 and is currently selling life and annuity products in the state of Texas. During 2018, TRCC made capital contributions of $2,000,000 and $750,000 bringing the total capitalization of TRLIC to $5,750,000. TRLS, an insurance agency, was incorporated February 1, 2017. The Company capitalized TRLS with $50,000 and owns 100% of TRLS. During 2018, TRCC made a capital contribution of $100,000 bringing the total capitalization of TRLS to $150,000.

From incorporation through April 2, 2017 the Company was involved in the sale of common stock to provide working capital. During this time the Company completed an organizational offering, three private placement stock offerings and an intrastate public stock offering in the state of Texas. The Company raised $10,336,500 and incurred $1,215,569 of offering costs through the issuance of 12,865,000 shares from the organizational offering and three private placement offerings. The intrastate public stock offering was registered to raise $25,000,000 by offering 5,000,000 shares of its common stock and ended on April 2, 2017. This offering raised $10,010,485 and incurred $1,444,127 of offering costs through the sale of 2,002,097 shares of the common stock.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Stemcell Holdings (STMM) 113% -1.0 26% 12,033 6,023 7,314 8,235 3,099 4,927 -5,116
FCCC (FCCC) 1.5 -61% 92 3 0 0 -56 -56 -82
Tapinator (TAPM) 0% 0.1 -99% 1,783 952 4,323 0 -1,762 -1,762 -260
Nogales Resources (NLRT) 0% 1 188 0 0 0 0 -1
Golden Growers Cooperative (GGRO) -0% 0% 26,919 2,171 42,425 -45 0 0 -3,508
Northern Power Systems (NPS) 22% 0.4 -27% 8,927 13,901 18,317 4,050 -2,379 -1,701 -670
Twin River Worldwide (TRWH) 0% 4.0 4% 1,070,918 808,153 393,158 0 41,775 112,100 449,560
Bio-En (BENH) 0.1 -643% 10 149 0 0 -67 -67 -5
Southwest Iowa Renewable Energy (SIRE) -1% -47.3 -1% 140,863 51,558 216,993 -1,931 -1,170 -537 25,396
Texas Republic Capital (TRCC) 0% 8.9 -5% 26,315 14,988 931 0 -1,274 -1,274 -11,328
Fannie Mae (FNM) 28.1 0% 3,494,436,000 3,484,094,000 0 0 13,025,000 119,732,000 3,361,548,000
CBA Florida (CBAI) 43.6 -1% 14,544 598 0 0 -211 -261 -11,368
Pacific Gold & Royalty (PCFG) -7.1 0 3,799 0 -3 -238 -45 320
BoxScore Brands (BOXS) 33% -8.3 -540% 313 7,564 338 110 -1,690 -702 5,793
Quest Management (QUEST) 27% -0.3 129% 13 6 45 12 16 16 -5
Zhen Ding Resources (RBTK) 0.1 48,309,900% 0 0 -483 -68 -6
Hines Global REIT (HGRI) 0% 1.7 19% 2,010,946 999,520 205,149 0 388,366 421,651 715,767
Wadena (WDN) 0% 0.0 -2,344% 12 696 87 0 -281 -278 -5
Galera Therapeutics (GRTX) 1.3 -17% 79,758 52,298 0 0 -13,351 -12,433 -15,719
Chase General (CSGN) 26% -0.5 -2% 1,563 1,016 2,493 658 -32 13 -7

Balance Sheet ($'000)2016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash9,29810,38610,78112,14911,76111,71212,57910,7589,9268,4196,5128,39710,58211,328
Accounts Receivable51413626202025231816144773171
Inventory
PP&E8891323364242282655353330
Assets11,77712,87013,18814,58114,28014,35415,34415,64616,06316,22115,73318,94222,07326,315
Accounts Payable
Long-Term Debt
Liabilities21731421304651,8042,5333,3243,7533,7047,06710,38814,988
Stockholders' Equity11,77512,85313,15614,53914,14913,89013,54013,11312,73912,46812,02911,87511,68611,327
Income Statement ($'000)2016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue23232324108153116137275204258386287
Cost of Revenue
Gross Profit
R&D
SG&A12276054444849444753445137
Tax
Net Income-202-258648-328-393-273-342-329-294-254-377-420-478
Cash Flow ($'000)2016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-236-271-326-367-317-245-356-366-217-67-514-661
Cash Investing0-2-4-10-13-6-2,112-1,129-1,647-494-393-2,969
Cash Financing1,3246681,698-112801,1186486643572,4473,0924,376